Summit Therapeutics
SMMT
SMMT
41 hedge funds and large institutions have $54.6M invested in Summit Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.12% more ownership
Funds ownership: 11.09% → 11.21% (+0.12%)
Holders
41
Holding in Top 10
–
Calls
$90K
Puts
–
Top Buyers
| 1 | +$2.11M | |
| 2 | +$1.94M | |
| 3 | +$621K | |
| 4 |
Goldman Sachs
New York
|
+$304K |
| 5 |
LCS
Levin Capital Strategies
New York
|
+$197K |
Top Sellers
| 1 | -$2.75M | |
| 2 | -$1.08M | |
| 3 | -$542K | |
| 4 |
BP
BBR Partners
New York
|
-$235K |
| 5 |
Morgan Stanley
New York
|
-$228K |